IRVINE, CA / ACCESSWIRE / June 6, 2023 / GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce bestinclass biomedical research reagents. The specificity of these new antibodies is established through meticulous inhouse validation testing based on knockdown/knockout methodologies complemented by other strategies.... Lire le communiqué |